

















































Prediction of ischaemic stroke in non-valvular
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This editorial refers to ‘Left atrial function to identify
patients with atrial fibrillation at high risk of stroke:
new insights from a large registry’†, by M.L. Leung et al., on
page 1416.
Atrial fibrillation (AF) presents a five-fold increase of the risk for ischae-
mic stroke and 20–30% of ischaemic strokes appear to be directly
associated with AF.1 Currently, the need for anticoagulation for non-
valvular AF is assessed on the basis of clinical parameters using the
CHAD2DS2-VASc score.
2 Conventional echocardiographic parame-
ters such as left atrial (LA) dilatation, LA appendage thrombus >
sludge > smoke, and reduced LA appendage velocities (<20 cm/s) can
further risk stratify AF patients who would most benefit from anticoa-
gulation.3 However, most of these parameters require transoesopha-
geal echocardiography and do not evaluate the full risk spectrum
related to LA functional impairment in AF. Moreover, whether they
remain predictive of stroke after adjustment for comorbid factors (e.g.
age, hypertension, diabetes, and previous stroke), which are the most
critical upstream concomitant conditions promoting atrial remodelling,
has not been well examined. Beyond the usual methods, including
transmitral flow and changes in LA area and volume, novel techniques
such as tissue Doppler imaging (TDI) and strain imaging provide more
accurate estimation of LA function. LA strain is correlated with LA fib-
rosis in patients with AF, is significantly reduced in those with prior
stroke, and predicts subsequent stroke.4 In their study, Leung et al. fur-
ther extended this observation in a large registry cohort of 1361
patients with first diagnosis of AF.5 At baseline echocardiography, LA
volumes, LA reservoir strain, P-wave to A’ duration (PA)-TDI (tissue
Doppler imaging), and left ventricular (LV) global longitudinal strain
were evaluated in patients with and without stroke. During follow-up
(mean: 7.9 years), 100 patients (7%) developed an ischaemic stroke,
representing an annualized stroke rate of 0.9% (1.2% in patients who
had a CHA2DS2-VASc score of <_1). LA reservoir strain was reduced
while PA-TDI was lengthened in the stroke compared with non-stroke
group, and emerged as independently associated with risk of stroke in
a model including CHA2DS2-VASc score, age, and anticoagulant use.
Notably, these two parameters fitting with the prediction of
ischaemic stroke have a deep physiopathological meaning, as they are
both an expression of LA function. PA-TDI represents LA electrome-
chanical delay and can be obtained by calculating the time duration
difference between the onset of the echocardiogram-derived P-wave
and the peak of the A’ wave on TDI.6 PA-TDI reflects the total LA
activation time, and is likely a surrogate measurement of myocardial
fibrosis and LA remodelling.6 PA-TDI has already been identified as
an independent predictor of new-onset,7 post-operative,8 and recur-
rent AF after electrical cardioversion.9 Moreover, in a large popula-
tion of 279 patients free of AF recurrence after successful catheter
ablation, it was shown that the longer the LA electromechanical
delay, the higher the risk of stroke.10 LA reservoir strain, i.e. the col-
lection of flow from pulmonary veins during LV systole, can be quan-
tified by two-dimensional speckle-tracking echocardiography as the
peak positive longitudinal strain during LV systole. LA reservoir strain
gives additional insights beyond traditional measures of LA remodel-
ling corresponding to LA enlargement, and its alteration is associated
with a number of cardiac diseases including AF.11 In recent studies,
LA reservoir strain has shown to provide incremental value for
thromboembolic risk stratification over CHAD2DS2-VASc score,
12
and has demonstrated a prognostic significance in various clinical set-
tings.13 Interestingly, in the study of Leung et al.,5 neither LA volume
nor LA conduit strain—expression of LA flow passage to the left ven-
tricle during early diastole—and LV dimensions, LV ejection fraction,
and global longitudinal strain predicted the risk of stroke. Of note,
the relationship between LV systolic dysfunction and ischaemic
stroke in AF is so evident that a reduced ejection fraction (<40%) as
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a surrogate of heart failure is already included in CHA2DS2-VASc risk
score.2
By identifying additional echocardiographic high-risk features,
Leung et al. have elegantly refined the stroke risk assessment in
patients with AF.5 The authors showed that adding advanced echo-
cardiographic parameters, LA reservoir strain, and PA-TDI to the
CHA2DS2-VASc risk stratification score improved the risk stratifica-
tion of AF patients, and this may be useful to guide decisions regard-
ing anticoagulation for patients upon first diagnosis of AF. It is known
that AF patients with stroke risk factors have more severe ultrastruc-
ture abnormalities, which implies more serious LA remodelling and
dysfunction with more stroke risk factors.4 Thus, higher CHA2DS2-
VASc is intuitively associated with more significant enlargement LA,
loss of atrial contraction, and reduced strain. Although, all this was
confirmed in the study of Leung et al., the prediction of ischaemic
stroke was observed independently of the CHA2DS2-VASc score.
5
Both categories of patients at low and high risk of stroke were strati-
fied in terms of stroke risk using LA reservoir strain and PA-TDI. In
practice, although the CHA2DS2-VASc score provides a good indica-
tion of stroke risk based on common clinical risk factors, there
remains the occurrence of stroke in patients with CHA2DS2-VASc
score <_1 (a rate of <_2.8% per year) in whom the European Society
of Cardiology Guidelines do not routinely recommend antithrom-
botic therapy.2 In this group of patients, it is therefore desirable to
provide personalized treatment according to tailored risk stratifica-
tion, even if it is not well codified. The upcoming European
Association of Cardiovascular Imaging AF Registry has been designed
to provide additional insights into the relationships between LA
structure and function with the development of ischaemic stroke and
individual patient bleeding risk profiles.14
While the above-mentioned strengths must be emphasized, the
only weakness of the study of Leung et al.5 corresponds to the use of
advanced echocardiography itself as possible means of supporting
CHA2DS2-VASc risk score in non-valvular AF patients. In particular,
PA-TDI is a parameter that presupposes the use of colour TDI, which
is angle-dependent and needs a high frame rate of recording.
Therefore, its application in routine clinical practice has gradually been
reduced. LA strain is a much more solid parameter, since it is obtain-
able on simple 2D images by speckle tracking echocardiography,
which has high feasibility and good reproducibility.3,15 However, this
technique is affected by a limited availability and the need for vendor-
specific software on dedicated workstations for post hoc analyses,
which cannot be obtained directly on the echocardiogram machine.
Because of its recognized value, echocardiography has become
established in guidelines for the management of AF.2 In fact, echocar-
diography has a unique and important role in the assessment of car-
diac structure and function, and risk stratification in AF patients.3
Altogether, the findings of Leung et al.5 state the important concept
that the assessment of LA function adds valuable information to con-
ventional clinical risk scores and improves the prediction of neuro-
logic outcomes in patients with non-valvular AF. This novel approach
has fundamental clinical implications and opens up new perspectives
for the use of echocardiography as a support to the CHA2DS2-VASc
risk score in AF patients with low–intermediate stroke risk. This
could drive clinicians to make more accurate choices regarding oral
anticoagulant therapy [oral anticoagulant (OAC)] in these delicate
categories. The introduction of OAC may in fact be promoted in
men with CHA2DS2-VASc = 1 and women with CHA2DS2-VASc =
2, when a functional LA impairment, detectable by the echocardiog-
raphy, is well evident (Take home figure). Beyond LA enlargement,
LA dysfunction can make AF patients more prone to the develop-
ment of LA internal cavity thrombi and subsequent ischaemic stroke.
Further prospective data are needed to confirm the incremental
prognostic value of LA function assessment in patients considered at
low–intermediate risk.
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Take home ﬁgure A futuristic echo-based algorithm for anti-
coagulant therapy management of patients with non-valvular atrial
fibrillation. OAC, oral anticoagulant therapy; LA, left atrial.
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